What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the food and drug administration

American Journal of Gastroenterology

Volumn 108, Issue 5, 2013, Pages 642-646

  Ehrenpreis, Eli D ^a   Kulkarni, Prasad ^b   Burke, Carol ^c  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b James A Haley VA Hospital   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUNTERFEIT DRUG;

ARTICLE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; GASTROENTEROLOGIST; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; HUMAN; INTERNET; PHARMACY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

EID: 84877310802     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.348     Document Type: Article

References (34)

1. Federal Digital System. About Code of Federal Regulations. http://www.gpoaccess.gov/cfr/about.html
2. US Food and Drug Administration. Federal Food, Drug, and Cosmetic Act. http://medical. cms.itri.org.tw/pdf/u01.pdf
3. US Food and Drug Administration. Text of the Prescription Drug Marketing Act of 1987. http://www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ PrescriptionDrugMarketingActof1987/ucm201702.htm
4. Pew Health Group. After Heparin: Protecting Consumers From the Risks of Substandard and Counterfeit Drugs .
5. Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011;100:4571-9.
6. Gautam CS, Utreja A, Singal GL. Spurious and counterfeit drugs: a growing industry in the developing world. Postgrad Med J 2009;85:251-6.
7. Sharfstein JM, US Food and Drug Administration, Department of Health and Human Services. Drug Safety: An Update from the FDA. http://www.hhs.gov/asl/ testify/2010/03/t20100310a.html
8. US Food and Drug Administration. FDA Initiative to Combat Counterfeit Drugs. http://www.fda.gov/Drugs/DrugSafety/ucm180899.htm
9. World Health Organization. Medicines: Spurious/Falsely-Labelled/ Falsified/Counterfeit (SFFC) Medicines. http://www.who.int/mediacentre/ factsheets/fs275/en
10. Ivanitskaya L, Brookins-Fisher J, O'Boyle I. Dirt cheap and without prescription: how susceptible are young US consumers to purchasing drugs from rogue internet pharmacies? J Med Internet Res [online] 2010;12:e11 (doi:10.2196/jmir.1520).
11. Orizio G, Merla A, Schulz PJ et al. Quality of online pharmacies and websites selling prescription drugs: a systematic review. J Med Internet Res [online] 2011;13:e74 (doi:10.2196/jmir.1795).
12. US Department of Justice, Office of Diversion Control. DEA Warning-Buying Drugs Online May Be Illegal and Dangerous .
13. US Food and Drug Administration. Dietary Supplement Health and Education Act. http://www.anh-usa.org/dshea/
14. US Food and Drug Administration. Dietary Supplement and Nonprescription Drug Consumer Protection Act. http://www.fda.gov/RegulatoryInformation/ Legislation/Federal-FoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/ucm148035.htm
15. US Food and Drug Administration. Current Good Manufacturing Practices (CGMPs). http://www.fda.gov/food/guidancecomplianceregulatoryinformation/ currentgoodmanufacturingpracticescgmps/default.htm
16. Weizman AV, Ahn E, Thanabalan R et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:342-9.
17. van Tilburg MA, Palsson OS, Levy RL et al. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. Complement Altern Med [online] 2008;8:46 (doi:10.1186/1472-6882-8-46).
18. Yoon SLJ, Grundmann O, Koepp L et al. Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches. Altern Med Rev 2011;16:134-51.
19. Ferrucci LM, Bell BP, Dhotre KB et al. Complementary and alternative medicine use in chronic liver disease patients. J Clin Gastroenterol 2010;44:e40-5.
20. Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci 2011;56:3288-95.
21. Saito YA, Rey E, Almazar-Elder AE et al. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome. Am J Gastroenterol 2010;105:170-7.
22. Langmead L, Rampton DS. Review article. Complementary and alternative therapies for inflammatory bowel disease. Aliment Pharm Ther 2006;23:341-9.
23. Holtmeier W, Zeuzem S, Preiss J et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy. Inflamm Bowel Dis 2011;17:573-82.
24. Ben-Arye E, Goldin E, Wengrower D et al. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 2002;37:444-9.
25. Allescher H-D, Wagner H. [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome] (German). Wien Med Wochenschr 2007;157:310-7.
26. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-36.
27. Joos S. Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease. Chin J Integr Med 2011;17:403-9.
28. Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009;29:373-82.
29. US Food and Drug Administration. Compliance Policy Guidance for FDA Staff and Industry. Sec. 460.200 Pharmacy Compounding. http://www.fda.gov/ICECI/ ComplianceManuals/CompliancePolicyGuidanceManual/ucm074398.htm
30. US Food and Drug Administration. FDA Talk Paper: FDA Warns Against Women Using Unapproved Drug, Domperidone, to Increase Milk Production. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm
31. Galston SK, US Food and Drug Administration, Department of Health and Human Services. Federal and State Role in Pharmacy Compounding and Reconstitution: Exploring the Right Mix to Protect Patients . Accessed 23 February 2012.
32. Gargis P. Nine die in Alabama during bacteria outbreak. Reuters (2011). Accessed 23 February 2012. http://www.reuters.com/article/2011/03/30/us-alabama- bacteriadeaths-idUSTRE72T0CW20110330
33. Outterson K. Regulating compounding pharmacies after NECC. N Engl J Med 2012;367:1969-72.
34. US Food and Drug Administration. Counterfeit Medicine. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/ CounterfeitMedicine/default.htm